Pacific Basin Shipping (2343.HK) traded down -1.51 % during a 24 hours period ending at 09:34 PM Central Europe on Monday 26th. One Pacific Basin Shipping stock can currently be bought for about HKD 3.74 on popular exchanges. Current supply of Pacific Basin Shipping stocks is 5.1 bn. Pacific Basin Shipping has a current market capitalization of HKD 18.3 bn and approximately HKD 31.3 mn worth of Pacific Basin Shipping was traded on exchanges in the last 24 hours. Since last month end, Pacific Basin Shipping has traded -12.64 % down. Simple moving average of last 200 days is at HKD 3.32. The highest price of past 52 weeks was recorded at HKD 4.45 on 09/09/2026. 52 weeks low was at HKD 2.23 on 12/17/2025.

Here is how related stocks have performed in the past 24 hours:

  • Insilico Medicine Cayman Top (3696.HK) traded up 1.22 % and now trades at HKD 36.5. Insilico Medicine Cayman Top has a market capitalisation of HKD 21 bn.

  • Easy Smart Lt-h (2442.HK) traded up 2.31 % and now trades at HKD 64. Current market capitalisation for Easy Smart Lt-h is HKD 19.9 bn.

  • Gcl (3800.HK) traded down -4 % and now trades at HKD 0.61. Gcl has a market capitalisation of HKD 19.3 bn.

  • Tianhai Auto Electronics G (001365.SZ) traded flat 0 % and now trades at CNY 31.02. Tianhai Auto Electronics G has a market capitalisation of CNY 16.7 bn. Tianhai Auto Electronics G has a current price to earnings ratio of 29.18.

  • Hutchmed China (0013.HK) traded up 0.98 % and now trades at HKD 22.56. Hutchmed China has a market capitalisation of HKD 19.6 bn. Hutchmed China has a current price to earnings ratio of 142.72. AstraZeneca’s experimental antibody drug conjugate, sonesitatug vedotin, has demonstrated a substantial survival benefit in a late‑stage gastric‑cancer study. In patients whose disease progressed after at least one line of therapy, the agent extended median overall survival by approximately five months compared with standard chemotherapy, while maintaining a manageable safety profile. The benefit was most pronounced in patients receiving the drug after two prior therapies. The data, presented at the European Society for Medical Oncology Congress, support the potential of sonesitatug vedotin to replace conventional chemotherapy in this setting and suggest a significant commercial opportunity for the company.

About Pacific Basin Shipping

Pacific Basin Shipping Limited offers marine transportation services and logistical support to its customers through the commercial operation of a large, modern, and uniformly-sized fleet of shallow-draft Handysize dry bulk carriers.